GlassScriptPhysician profile
Mark William Walberg
NPI 1306884333
$675.15
in general payments reported to CMS, 2019-2025
17 companies · $94.33 in 2025
The $94.33 reported for 2025 was less than what a typical Medical Oncology provider received nationally (typical 2025 total: $1,158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2020: $19.45 · 2021: $43.24 · 2022: $19.06 · 2023: $200 · 2024: $299 · 2025: $94.33.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $593.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $593.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Eisai INC. | $86.88 | 2021-2024 | |
| Astrazeneca Pharmaceuticals LP | $81.13 | 2024 | Imjudo, Imfinzi |
| Bayer Healthcare Pharmaceuticals INC. | $66.73 | 2020-2023 | |
| Incyte Corporation | $52.96 | 2023-2024 | Monjuvi |
| Janssen Scientific Affairs, LLC | $50.80 | 2025 | Tecvayli, Talvey, Darzalex |
| Seagen INC. | $46.64 | 2023 | Tukysa |
| Array Biopharma INC | $44.35 | 2023-2024 | Braftovi, Mektovi, Tukysa |
| Astellas Pharma US INC | $39.90 | 2021-2024 | Padcev |
| Pfizer INC. | $37.59 | 2024 | |
| Tempus Ai, INC | $30.20 | 2024 | |
| Legend Biotech USA INC. | $27.93 | 2025 | Carvykti |
| Aveo Pharmaceuticals, INC. | $23.63 | 2024 | |
| Sun Pharmaceutical Industries INC. | $23.17 | 2023 | Yonsa, Odomzo |
| Merck Sharp & Dohme LLC | $19.06 | 2022 | |
| Regeneron Healthcare Solutions, INC. | $16.66 | 2024 | Libtayo |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $15.60 | 2025 | |
| Gilead Sciences, INC. | $11.92 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Mark Walberg listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.